Molecular Partners Ag (MOLN) Equity Average (2022 - 2025)
Historic Equity Average for Molecular Partners Ag (MOLN) over the last 4 years, with Q3 2025 value amounting to $124127.2.
- Molecular Partners Ag's Equity Average fell 9985.58% to $124127.2 in Q3 2025 from the same period last year, while for Sep 2025 it was $124127.2, marking a year-over-year decrease of 9985.58%. This contributed to the annual value of $179947.9 for FY2024, which is 1876.04% down from last year.
- Molecular Partners Ag's Equity Average amounted to $124127.2 in Q3 2025, which was down 9985.58% from $135709.4 recorded in Q2 2025.
- In the past 5 years, Molecular Partners Ag's Equity Average ranged from a high of $138.2 million in Q2 2022 and a low of $124127.2 during Q3 2025
- Its 4-year average for Equity Average is $45.3 million, with a median of $242150.9 in 2023.
- In the last 5 years, Molecular Partners Ag's Equity Average skyrocketed by 2024.73% in 2023 and then plummeted by 9985.58% in 2025.
- Quarter analysis of 4 years shows Molecular Partners Ag's Equity Average stood at $252228.2 in 2022, then decreased by 16.54% to $210518.3 in 2023, then dropped by 23.56% to $160929.6 in 2024, then decreased by 22.87% to $124127.2 in 2025.
- Its Equity Average stands at $124127.2 for Q3 2025, versus $135709.4 for Q2 2025 and $152131.7 for Q1 2025.